EPO and IP Australia to launch a PCT pilot programme for Australian applicants
From March 2026, EPO and IP Australia will launch a two-year PCT pilot programme enabling Australian applicants to select the EPO as ISA and IPEA. Read more in our latest news item.
Webinar on EPO practice: G 2/21 and Inventive Step – Reliance on a Purported Technical Effect
In this on-demand webinar, we review selected decisions applying G 2/21 and share key takeaways for those working with European patent portfolios, particularly in the chemical and pharmaceutical sectors.
Added subject matter, unclear parameters - T 1184/23 and T 1440/23
Two recent decisions from the EPO’s Technical Board of Appeal (T 1184/23 and T 1440/23) highlight the complexities of drafting, prosecuting and defending chemical patent applications with parametric definitions in the claims. Our latest article explains the key takeaways from both cases, offering practical guidance for applicants navigating clarity and added subject matter requirements before the EPO.
Divisional applications at the European Patent Office
There are several formal and practical aspects to keep in mind when filing divisional applications at the European Patent Office. Learn more in this article.
A guide to ‘further processing’ at the European Patent Office
Beyond remedying missed deadlines, further processing can offer valuable flexibility during European patent prosecution. Learn how to leverage it effectively as part of a coordinated global filing strategy.
Using ‘PACE’ at the EPO
Need faster patent prosecution in Europe? This guide explains how to use the European Patent Office’s PACE programme to accelerate search and examination timelines. Learn key requirements, risks, and strategic considerations from a European and UK patent attorney.